Literature DB >> 14678631

HIV and the transmission of Leishmania.

R Molina1, L Gradoni, J Alvar.   

Abstract

In many countries, Leishmania/HIV co-infection is now changing the epidemiology of visceral leishmaniasis. The levels of transmission of the parasites causing such leishmaniasis were previously dependent on the conventional zoonotic cycle, in which sandflies transmitted the parasites from infected canids to other canids or humans. The co-infection, however, has led not only to marked increases in the sandfly transmission of the parasites from immunodepressed individuals directly to other humans but also, probably, to artificial transmission between immunodepressed intravenous-drug users, as the result of needle sharing.

Entities:  

Mesh:

Year:  2003        PMID: 14678631     DOI: 10.1179/000349803225002516

Source DB:  PubMed          Journal:  Ann Trop Med Parasitol        ISSN: 0003-4983


  29 in total

1.  Differential microbicidal effects of human histone proteins H2A and H2B on Leishmania promastigotes and amastigotes.

Authors:  Yingwei Wang; Yang Chen; Lijun Xin; Stephen M Beverley; Eric D Carlsen; Vsevolod Popov; Kwang-Poo Chang; Ming Wang; Lynn Soong
Journal:  Infect Immun       Date:  2010-12-28       Impact factor: 3.441

Review 2.  Drug resistance in leishmaniasis.

Authors:  Simon L Croft; Shyam Sundar; Alan H Fairlamb
Journal:  Clin Microbiol Rev       Date:  2006-01       Impact factor: 26.132

3.  Visceral Leishmaniasis in Hospitalized HIV-Infected Patients in Pernambuco, Brazil.

Authors:  Diego Lins Guedes; Zulma Medeiros; Elis Dionísio da Silva; Audrey Violeta Martins de Vasconcelos; Mariana Santana da Silva; Maria Almerice Lopes da Silva; Paulo Sérgio Ramos de Araújo; Demócrito de Barros Miranda-Filho
Journal:  Am J Trop Med Hyg       Date:  2018-12       Impact factor: 2.345

Review 4.  Tissue Parasites in HIV Infection.

Authors:  Eva H Clark; Jose A Serpa
Journal:  Curr Infect Dis Rep       Date:  2019-11-16       Impact factor: 3.725

Review 5.  Leishmaniasis treatment--a challenge that remains: a review.

Authors:  Dilvani O Santos; Carlos E R Coutinho; Maria F Madeira; Carolina G Bottino; Rodrigo T Vieira; Samara B Nascimento; Alice Bernardino; Saulo C Bourguignon; Suzana Corte-Real; Rosa T Pinho; Carlos Rangel Rodrigues; Helena C Castro
Journal:  Parasitol Res       Date:  2008-06       Impact factor: 2.289

6.  Drug resistance in leishmaniasis.

Authors:  Jaya Chakravarty; Shyam Sundar
Journal:  J Glob Infect Dis       Date:  2010-05

7.  Nelfinavir, an HIV-1 protease inhibitor, induces oxidative stress-mediated, caspase-independent apoptosis in Leishmania amastigotes.

Authors:  Pranav Kumar; Robert Lodge; Nathalie Trudel; Michel Ouellet; Marc Ouellette; Michel J Tremblay
Journal:  PLoS Negl Trop Dis       Date:  2010-03-30

Review 8.  The immunology of Leishmania/HIV co-infection.

Authors:  Ifeoma Okwor; Jude Eze Uzonna
Journal:  Immunol Res       Date:  2013-05       Impact factor: 2.829

9.  The first case of isolated facial cutanenous leishmaniasis in a Down syndrome infant: a case report and review of the literature.

Authors:  Kotb Abass; Hekma Saad; Alaa A Abd-Elsayed
Journal:  Cases J       Date:  2009-01-06

10.  Tropical Parasitic Infections in Individuals Infected with HIV.

Authors:  Emily E Evans; Mark J Siedner
Journal:  Curr Trop Med Rep       Date:  2017-10-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.